1. Home
  2. PLSE vs CNS Comparison

PLSE vs CNS Comparison

Compare PLSE & CNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pulse Biosciences Inc (DE)

PLSE

Pulse Biosciences Inc (DE)

N/A

Current Price

$58.29

Market Cap

3.6B

Sector

Health Care

ML Signal

N/A

Logo Cohen & Steers Inc

CNS

Cohen & Steers Inc

N/A

Current Price

$75.17

Market Cap

3.6B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
PLSE
CNS
Founded
2014
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.6B
IPO Year
2015
2004

Fundamental Metrics

Financial Performance
Metric
PLSE
CNS
Price
$58.29
$75.17
Analyst Decision
Strong Buy
Hold
Analyst Count
6
3
Target Price
$66.67
★ $69.33
AVG Volume (30 Days)
★ 364.5K
272.2K
Earning Date
11-05-2026
10-15-2026
Dividend Yield
N/A
★ 3.66%
EPS Growth
N/A
N/A
EPS
N/A
★ 2.58
Revenue
N/A
★ $427,536,000.00
Revenue This Year
$480.71
$9.41
Revenue Next Year
$177.98
$5.94
P/E Ratio
★ N/A
$28.48
Revenue Growth
N/A
★ 4.07
52 Week Low
$12.56
$58.39
52 Week High
$58.90
$86.56

Technical Indicators

Market Signals
Indicator
PLSE
CNS
Relative Strength Index (RSI) 62.63 57.51
Support Level $49.01 $73.07
Resistance Level N/A $77.74
Average True Range (ATR) 3.63 2.22
MACD 0.41 0.61
Stochastic Oscillator 89.60 78.35

Price Performance

Historical Comparison
PLSE
CNS

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.

About CNS Cohen & Steers Inc

Cohen & Steers is a niche asset manager concentrating on real estate securities. The firm invests primarily in the equity shares of real estate investment trusts, with holdings in domestic and international real estate securities accounting for nearly two-thirds of its $102.5 billion in managed assets at the end of July 2026. Cohen & Steers also manages portfolios dedicated to preferred securities, utilities stocks, and other high-yield offerings. The firm's distribution is balanced among its closed-end funds, open-end funds, and institutional accounts. During the past four calendar quarters, the company garnered 39% (25%) of its managed assets (base management fees) from institutional clients, 48% (55%) from open-end funds, and 13% (20%) from closed-end funds.

Share on Social Networks: